Apoptosis and phagocytosis of tissue-dwelling eosinophils in sinonasal polyps

Laryngoscope

Volumn 110, Issue 1, 2000, Pages 111-116

  Davidsson, Åke ^a,b   Andersson, Tina ^c   Hellquist, Henrik B ^c,d  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c LINKÖPING UNIVERSITY   (Sweden)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Allergy; Apoptosis; Cytokines; Eosinophils; Lymphocytes; Macrophages; Nasal polyps

Indexed keywords

ANNEXIN; CD68 ANTIGEN; CYTOKINE; FAS ANTIGEN;

ALLERGIC RHINITIS; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; EOSINOPHIL; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; NOSE POLYP; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0033958977     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200001000-00020     Document Type: Article

References (51)

1. Braun JJ, Haas F, Conraux C. La polypose nasosinusienne epidémiologie et clinique sur 350 cas. Traitement et résultats avec un recul supérieur à 5 ans sur 93 cas. Ann Otolaryngol (Paris) 1992;109:189-199.
2. Stoop AE, van der Heijden HAMD, Biewenga J, van der Baan S. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids. Eur Arch Otorhinolaryngol 1992;249: 313-317.
3. Davidsson Å, Hellquist HB. The so-called "allergic" nasal polyp. ORL J Relat Spec 1993;55:30-35.
4. Liu C-M, Shun C-T, Hsu M-M. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps. Ann Allergy 1994;72:19-24.
5. Hellquist HB. Histopathology of nasal polyps. Allergy Asthma 1996;17:237-242.
6. Masuyama K, Samejima Y, Ishikawa T. Nasal tissue eosinophils in allergic rhinitis. Auris Nasus Larynx 1993;20: 302-313.
7. Yoshimi R, Takamura H, Takasaki K, Tsurumoto H, Kumagami H. Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma. Nippon Jibiinkoka Gakkai Kaiho 1993;96:1922-1925.
8. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993;91: 616-622.
9. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994;180:371-376.
10. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:624-632.
11. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-2289.
12. Elovic A, Wong DT, Weller PF, Matossian K, Galli SKJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93:864-869.
13. Davidsson Å, Danielsen A, Viale G, et al. Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Acta Otolaryngol (Stockh) 1996;116:604-610.
14. Wardlaw AJ, Symon FS, Walsh GM. Eosinophil adhesion in allergic inflammation. J Allergy Clin Immunol 1994;94: 1163-1171.
15. Karlsson MG, Hellquist HB. Endothelial adhesion molecules for nasal-homing T cells in allergy. Virchows Arch 1996; 429:49-54.
16. Desreumaux P, Capron M. Immunobiology of eosinophils in mucosal tissues. Mucosal Immunol Update 1996;4:45-8.
17. Westergren V, Viale G, DellíOrto P, Pellegrini C, Hellquist HB. RANTES is more prevalent in bacterial than non-bacterial maxillary sinusitis and P-selectin is preferentially upregulated in diseased mucosae. Arch Otolaryngol Head Neck Surg 1997;123:1103-1110.
18. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996;154:237-243.
19. Tsuyuki S, Bertrand C, Erard F, et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995;96:2924-2931.
20. Biffl WL, Moore EE, Moore FA, Barnett CC Jr. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma 1996;40:575-578.
21. Mullol J, Xaubet A, Gaya A, et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995;25:607-615.
22. Jordana M. Eosinophil controversies: is the end near? Mucosal Immunol Update 1996;4:41-45.
23. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-842.
24. Pretolani M, Goldman M. Cytokines involved in the down-regulation of allergic airway inflammation. Res Immunol 1997;148:33-38.
25. Till S, Walker S, Dickason R, et al. IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin Exp Immunol 1997;110:114-121.
26. Hebestreit H, Yousefi S, Balatti I, et al. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol 1996;26:1775-1780.
27. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-1443.
28. Matsukura M, Yamada H, Yudate T, Tezuka T, Chihara J. Steroid-induced changes of eosinophils in atopic dermatitis. Int Arch Allergy Immunol 1997;114(suppl 1):51-4.
29. Soda K, Kawabori S, Kanai N, Bienenstock J, Perdue MH. Steroid-induced depletion of mucosal mast cells and eosinophils in intestine of athymic nude rats. Int Arch Allergy Immunol 1993;101:39-46.
30. Terenzi F, Diaz GM, Casado M, Hortolano S, Leoni S, Bosca L. Bacterial lipopeptides induce nitric oxide synthase and promote apoptosis through nitric oxide-independent pathways in rat macrophages. J Biol Chem 1995;270: 6017-6021.
31. Pradhan D, Williamson P, Schlegel RA. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids. Mol Membr Biol 1994;11:101-107.
32. Hart SP, Haslett C, Dransfield I. Recognition of apoptotic cells by phagocytes. Experimentia 1996;52:950-956.
33. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
34. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J Cell Biol 1992;119:493-501.
35. Duffy JP, Smith PJ, Crocker J, Matthews HR. Combined staining method for the demonstration of tissue eosinophils and mast cells. J Histotech 1993;16:143-145.
36. Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M, Viale G. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997;181:323-329.
37. Hellquist HB, Olejnicka B, Jadner M, Andersson T, Sederholm C. Fas-receptor is expressed in human lung squamous cell carcinomas whereas bcl-2 and apoptosis are not pronounced. A preliminary report. Br J Cancer 1997;76: 175-179.
38. Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 1997;33:1860-1864.
39. Nakajima H, Iwamoto S, Tomoe R, et al. CD4+ lymphocytes and interleukin-5 mediate antigen induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 144:374-379.
40. Coyle AJ, Le Gros G, Bertrand C, et al. IL-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54-59.
41. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL. Activation and regulation of chemokines in allergic airway inflammation. J Leukoc Biol 1996;59:13-17.
42. Wardlaw A. The eosinophil: new insights into its function in human health and disease [editorial]. J Pathol 1996;179: 355-357.
43. Terada N, Konno A, Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994;94: 629-642.
44. - T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996;183:1071-1082.
45. van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res 1997;235: 421-430.
46. Simon H-U, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 1995;16:53-55.
47. Jones J, Morgan BP. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes. Immunology 1995;86:651-660.
48. Kay AB, Barata L, Meng Q, Durham SR, Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 1997;113:196-199.
49. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon H-U. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996;183:1407-1414.
50. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils: programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992;148:3543-3549.
51. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996;183:657-661.